Clinical psychologists at medical device firm Flow Neuroscience have offered guidance to support and manage mental health during the COVID-19 pandemic.
The Swedish startup says that its brain stimulation headset is a modern drug-free treatment for depression, which does not require health services, such as the NHS.
Clinical studies published in the New England Journal of Medicine and the British...
Flow Neuroscience is working with outpatient clinics in London’s Harley Street district in a partnership that will see its brain stimulation headset be offered to patients as an add-on treatment for depression.
The Swedish startup announced this morning that around 10 centres, including the Chelsea Psychology Clinic, would start offering the device in combination with traditional therapy and...
Malmö-based medical device startup Flow has landed $1.5m (approximately €1.35m) in funding in a round led by Khosla Ventures, it was announced this week. The new funds will be used to support the European rollout of Flow's brain stimulation headset and therapy app, developed to treat depression, which were launched in the UK and Sweden earlier this year.
“The Khosla Ventures investment will...
This morning, Malmö-based medical device company Flow has announced that it is launching its brain stimulation headset and therapy app to treat depression in the UK.
HOW IT WORKS
Priced at £399, the headset uses transcranial direct current stimulation (tDCS) - a non-invasive treatment using direct electronic currents to stimulate specific parts of the brain in order to help rebalance activity,...
Halo Neuroscience, a device company that develops and sells the Halo Sport neurostimulation headset, announced yesterday that it has secured $13 million in Series B funding. Global private investment firm TPG led the round, which also had participation from prior investors Lux Capital, JAZZ Ventures Partners, and Xfund.
The Halo Sport headset connects to a paired mobile app to promote brain...
